EGF Protects Cells Against Dox-Induced Growth Arrest Through Activating Cyclin D1 Expression
EGF Protects Cells Against Dox-Induced Growth Arrest Through Activating Cyclin D1 Expression
复制标题
EGF 通过激活细胞周期蛋白 D1 表达来保护细胞免受 Dox 诱导的生长停滞
DOI:
10.1002/jcb.25134
复制
发表时间:
2015
影响因子:
4
通讯作者:
Xue Li-Xiang
中科院分区:
文献类型:
--
作者:
Yao Chun-Xia;Shi Jia-Chen;Ma Cai-Xia;Xiong Cheng-Juan;Song Yang-Liu;Zhang Shu-Feng;Zhang Shan-Feng;Zang Ming-Xi;Xue Li-Xiang
It has been reported that the antitumor drug doxorubicin (Dox) exerts its toxic effects via GATA‐4 depletion and that over‐expression of GATA‐4 reverses Dox‐induced toxicity and apoptosis; however, the precise mechanisms remain unclear. In this study, we observed, for the first time, that EGF protects cells against Dox‐mediated growth arrest, G2/M‐phase arrest, and apoptosis. Additionally, EGF expression was down‐regulated in Dox‐treated cells and up‐regulated in GATA‐4 over‐expressing cells. Utilizing real‐time PCR and western blotting analysis, we found that the expression of the cell cycle‐associated protein cyclin D1 was inhibited in GATA‐4‐silenced cells and Dox‐treated cells and was enhanced in GATA‐4 over‐expressing cells and EGF‐treated cells. Furthermore, EGF treatment reversed the inhibited expression of cyclin D1 that was mediated by GATA‐4 RNAi or Dox. Our results indicate that EGF, as a downstream target of Dox, may be involved in Dox‐induced toxicity as well as in the protective role of GATA‐4 against toxicity induced by Dox via regulating cyclin D1 expression, which elucidates a new molecular mechanism of Dox toxicity with important clinical implications. J. Cell. Biochem. 116: 1755–1765, 2015. © 2015 Wiley Periodicals, Inc.